The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells
Molecular Immunology · 2024-10 · 174 · 1-10
DOI: 10.1016/j.molimm.2024.07.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Immunology, 2024-10. Verfasst von Fei Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biological and Medical Imaging (IBMI), Helmholtz Center Munich and Department of Oncology, The second affiliated Hospital of Zunyi Medic…. Hauptthemen laut MEDLINE: Cannabidiol, Killer Cells, Natural, Lymphocyte Activation, HSP70 Heat-Shock Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung Wissenschaft Forschung und Technologie Dienststelle Berlin, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
BACKGROUND: Cannabidiol (CBD), the major non-psychoactive component of cannabis, exhibits anti-inflammatory properties, but less is known about the immunomodulatory potential of CBD on activated natural killer (NK) cells and/or their targets. Many tumor cells present heat shock protein 70 (Hsp70) on their cell surface in a tumor-specific manner and although a membrane Hsp70 (mHsp70) positive phenotype serves as a target for Hsp70-activated NK cells, a high mHsp70 expression is associated with tumor aggressiveness. This study investigated the immuno-modulatory potential of CBD on NK cells stimulated with TKD Hsp70 peptide and IL-2 (TKD+IL-2) and also on HCT116 p53wt and HCT116 p53-/- colorectal cancer cells exhibiting high and low basal levels of mHsp70 expression. RESULTS: Apart from an increase in the density of NTB-A and a reduced expression of LAMP-1, the expression of all other activatory NK cell receptors including NKp30, NKG2D and CD69 which are significantly up-regulated after stimulation with TKD+IL-2 remained unaffected after a co-treatment with CBD. However, the release of major pro-inflammatory cytokines by NK cells such as interferon-γ (IFN-γ) and the effector molecule granzyme B (GrzB) was significantly reduced upon CBD treatment. With respect to the tumor target cells, CBD significantly reduced the elevated expression of mHsp70 but had no effect on the low basal mHsp70 expression. Expression of other NK cell ligands such as MICA and MICB remained unaffected, and the NK cell ligands ULBP and B7-H6 were not expressed on these target cells. Consistent with the reduced mHsp70 expression, treatment of both effector and target cells with CBD reduced the killing of high mHsp70 expressing tumor cells by TKD+IL-2+CBD pre-treated NK cells but had no effect on the killing of low mHsp70 expressing tumor cells. Concomitantly, CBD treatment reduced the TKD+IL-2 induced increased release of IFN-γ, IL-4, TNF-α and GrzB, but CBD had no effect on the release of IFN-α when NK cells were co-incubated with tumor target cells. CONCLUSION: Cannabidiol (CBD) may potentially diminish the anti-tumor effectiveness of TKD+IL-2 activated natural killer (NK) cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biological and Medical Imaging (IBMI), Helmholtz Center Munich and Department of Oncology, The second affiliated Hospital of Zunyi Medical University, Zunyi, China; Radiation Immuno-Oncology Group, TranslaT…
- Department of Otolaryngology, Head and Neck Surgery, Klinikum rechts der Isar, TUM School of Medicine and Health, Munich, Germany.
- Radiation Immuno-Oncology Group, TranslaTUM - Central Institute for Translational Cancer Research and Department of Radiation Oncology, Klinikum rechts der Isar, TUM School of Medicine and Health, Munich, Germany. Elect…
Förderung
- Bundesministerium für Bildung Wissenschaft Forschung und Technologie Dienststelle Berlin
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Wang, F., Bashiri Dezfouli, A., & Multhoff, G. (2024). The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells. Molecular Immunology, 174, 1-10. https://doi.org/10.1016/j.molimm.2024.07.008
Vancouver
Wang F, Bashiri Dezfouli A, Multhoff G. The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells. Molecular Immunology. 2024;174:1-10. doi:10.1016/j.molimm.2024.07.008
BibTeX
@article{Wang2024,
author = {Wang, Fei and Bashiri Dezfouli, Ali and Multhoff, Gabriele},
title = {The immunomodulatory effects of cannabidiol on Hsp70-activated NK cells and tumor target cells},
journal = {Molecular Immunology},
year = {2024},
volume = {174},
pages = {1--10},
doi = {10.1016/j.molimm.2024.07.008}
}
EUVIMED